candidate drug against malaria

Innovative candidate drug against malaria offers considerable potential

XenoGesis has been working with TropIQ and their Nijmegen-led collaboration on the generation of an innovative candidate drug against malaria.

A molecule that was once designed to cure the skin disease psoriasis has shown to be effective against malaria. The antimalarial properties were revealed thanks to a researcher’s inspired hunch when the psoriasis drug discovery programme came to a dead end. The candidate drug offers considerable potential for combatting the highly infectious malaria disease.

The research that led to this candidate has been published in Science Translational Medicine. To read the full press release from TropIQ, click here.

XenoGesis has been involved in this project and has worked with TropIQ on a number of projects over the last three years including supporting their research into vector-bone disease control.


If you’d like to get in touch with one of our scientists, please click here!